These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29147662)

  • 21. Bacteriophages to Control Multi-Drug Resistant
    El-Telbany M; El-Didamony G; Askora A; Ariny E; Abdallah D; Connerton IF; El-Shibiny A
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Novel
    Lee D; Im J; Na H; Ryu S; Yun CH; Han SH
    Front Microbiol; 2019; 10():2877. PubMed ID: 31921055
    [No Abstract]   [Full Text] [Related]  

  • 23. Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1.
    Son JS; Jun SY; Kim EB; Park JE; Paik HR; Yoon SJ; Kang SH; Choi YJ
    J Appl Microbiol; 2010 May; 108(5):1769-79. PubMed ID: 19863688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.
    Biswas B; Adhya S; Washart P; Paul B; Trostel AN; Powell B; Carlton R; Merril CR
    Infect Immun; 2002 Jan; 70(1):204-10. PubMed ID: 11748184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model.
    Gelman D; Beyth S; Lerer V; Adler K; Poradosu-Cohen R; Coppenhagen-Glazer S; Hazan R
    Res Microbiol; 2018 Nov; 169(9):531-539. PubMed ID: 29777835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of an
    Song M; Wu D; Hu Y; Luo H; Li G
    Front Cell Infect Microbiol; 2021; 11():698807. PubMed ID: 34336721
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibacterial effect of genetically-engineered bacteriophage ϕEf11/ϕFL1C(Δ36)P
    Tinoco JM; Liss N; Zhang H; Nissan R; Gordon W; Tinoco E; Sassone L; Stevens R
    Arch Oral Biol; 2017 Oct; 82():166-170. PubMed ID: 28646693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological characteristics and whole-genome analysis of the
    Xiang Y; Li W; Song F; Yang X; Zhou J; Yu H; Ji X; Wei Y
    Can J Microbiol; 2020 Sep; 66(9):505-520. PubMed ID: 32374181
    [No Abstract]   [Full Text] [Related]  

  • 29. Loss-of-Function Mutations in
    Ho K; Huo W; Pas S; Dao R; Palmer KL
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104266
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antimicrobial effect of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212.
    Paisano AF; Spira B; Cai S; Bombana AC
    Oral Microbiol Immunol; 2004 Oct; 19(5):327-30. PubMed ID: 15327646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage infection and sub-lethal antibiotic exposure mediate Enterococcus faecalis type VII secretion system dependent inhibition of bystander bacteria.
    Chatterjee A; Willett JLE; Dunny GM; Duerkop BA
    PLoS Genet; 2021 Jan; 17(1):e1009204. PubMed ID: 33411815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-biofilm Activity of a Lytic Phage Against Vancomycin-Resistant
    Goodarzi F; Hallajzadeh M; Sholeh M; Talebi M; Pirhajati Mahabadi V; Amirmozafari N
    Iran J Pathol; 2022; 17(3):285-293. PubMed ID: 36247507
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Lossouarn J; Briet A; Moncaut E; Furlan S; Bouteau A; Son O; Leroy M; DuBow MS; Lecointe F; Serror P; Petit MA
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30634666
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.
    Yoong P; Schuch R; Nelson D; Fischetti VA
    J Bacteriol; 2004 Jul; 186(14):4808-12. PubMed ID: 15231813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast Michigan.
    Omotola AM; Li Y; Martin ET; Alshabani K; Yadav D; Sarkar M; Thapa SD; Kumar V; Mahabashya A; Ahmad S; Bhargava A; Marchaim D; Pogue JM; Rybak MJ; Kaye KS; Hayakawa K
    Am J Infect Control; 2013 Dec; 41(12):1244-8. PubMed ID: 24011554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHARACTERIZATION OF ENTEROCOCCUS BACTERIOPHAGES FROM THE SMALL INTESTINE OF THE RAT.
    ROGERS CG; SARLES WB
    J Bacteriol; 1963 Jun; 85(6):1378-85. PubMed ID: 14047233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Phage Therapy in the Context of
    Bolocan AS; Upadrasta A; Bettio PHA; Clooney AG; Draper LA; Ross RP; Hill C
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31010053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Enterococcus faecalis biofilms with phage therapy.
    Khalifa L; Brosh Y; Gelman D; Coppenhagen-Glazer S; Beyth S; Poradosu-Cohen R; Que YA; Beyth N; Hazan R
    Appl Environ Microbiol; 2015 Apr; 81(8):2696-705. PubMed ID: 25662974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains.
    D'Andrea MM; Frezza D; Romano E; Marmo P; Henrici De Angelis L; Perini N; Thaller MC; Di Lallo G
    J Glob Antimicrob Resist; 2020 Jun; 21():68-75. PubMed ID: 31678321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.